Ling Xi

1.8k total citations
36 papers, 588 citations indexed

About

Ling Xi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ling Xi has authored 36 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Ling Xi's work include Cervical Cancer and HPV Research (4 papers), Virus-based gene therapy research (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Ling Xi is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Virus-based gene therapy research (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Ling Xi collaborates with scholars based in China, United States and Singapore. Ling Xi's co-authors include Ding Ma, Gang Chen, Ying Zhou, Fei Li, Xiangyi Ma, Shixuan Wang, Peng Wu, Rui Wei, Ding Ma and Guiying Jiang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ling Xi

35 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Xi China 15 259 204 95 74 72 36 588
Yuh-Cheng Yang Taiwan 12 141 0.5× 156 0.8× 165 1.7× 132 1.8× 93 1.3× 18 576
Sei Kyung Chang South Korea 12 163 0.6× 252 1.2× 259 2.7× 62 0.8× 102 1.4× 28 692
Travis Solley United States 13 342 1.3× 373 1.8× 52 0.5× 70 0.9× 93 1.3× 26 768
Hiromitsu Yabushita Japan 14 213 0.8× 117 0.6× 57 0.6× 65 0.9× 67 0.9× 50 579
Masanobu Momose Japan 14 222 0.9× 83 0.4× 133 1.4× 86 1.2× 207 2.9× 27 614
Hung-Cheng Lai Taiwan 9 248 1.0× 101 0.5× 33 0.3× 129 1.7× 67 0.9× 29 461
Diana P. English United States 14 183 0.7× 275 1.3× 53 0.6× 65 0.9× 41 0.6× 31 676
Partha Mukhopadhyay India 13 337 1.3× 171 0.8× 107 1.1× 38 0.5× 74 1.0× 41 618
Ivana Rizzuto United Kingdom 10 141 0.5× 150 0.7× 38 0.4× 31 0.4× 46 0.6× 24 457
Annie-France Bringuier France 12 170 0.7× 89 0.4× 51 0.5× 31 0.4× 71 1.0× 15 390

Countries citing papers authored by Ling Xi

Since Specialization
Citations

This map shows the geographic impact of Ling Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xi more than expected).

Fields of papers citing papers by Ling Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xi. The network helps show where Ling Xi may publish in the future.

Co-authorship network of co-authors of Ling Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xi. A scholar is included among the top collaborators of Ling Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xi. Ling Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, Zhenzhong Zhang, Lingling Wang, et al.. (2024). Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 51(8). 2338–2352. 6 indexed citations
3.
Li, Jiaqi, Yuan Li, Xuan Zhou, et al.. (2021). Upregulation of IL-15 in the placenta alters trophoblasts behavior contributing to gestational diabetes mellitus. Cell & Bioscience. 11(1). 33–33. 13 indexed citations
5.
Huang, Jia, Wanying Shan, Na Li, et al.. (2020). Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice. Reproductive BioMedicine Online. 42(3). 505–519. 45 indexed citations
6.
Xi, Ling, et al.. (2020). Polo-like kinase 1 is involved in apoptosis, invasion, and metastasis of pancreatic ductal adenocarcinoma. Translational Cancer Research. 9(11). 6672–6682. 3 indexed citations
7.
Wang, Chen, Ying Zhou, Wěi Li, et al.. (2020). Dual modal fluorescent colposcope combined with near-infrared fluorescent dye TMTP1-PEG4-ICG to detect cervical lesions. Biomedical Optics Express. 11(12). 7120–7120. 3 indexed citations
8.
Li, Fei, Jiong Cai, Ying Zhou, et al.. (2019). Primary Preclinical and Clinical Evaluation of 68Ga-DOTA-TMVP1 as a Novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer. Clinical Cancer Research. 26(6). 1318–1326. 13 indexed citations
9.
Wang, Yi, Yifan Meng, Wending Li, et al.. (2019). Prevalence and Characteristics of hrHPV Infection among 414,540 Women: A Multicenter Study in Central and Eastern China. Journal of Cancer. 10(8). 1902–1908. 10 indexed citations
10.
Feng, Yun, Wei Li, Juan Xiao, et al.. (2019). The potential role of pregnancy-associated plasma protein-A2 in angiogenesis and development of preeclampsia. Hypertension Research. 42(7). 970–980. 16 indexed citations
11.
Gao, Peipei, Canhui Cao, Yifan Meng, et al.. (2019). Immune checkpoint inhibitors in the treatment of virus-associated cancers. Journal of Hematology & Oncology. 12(1). 58–58. 46 indexed citations
12.
Zhu, Da, Hui Shen, Songwei Tan, et al.. (2018). Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy. Molecular Therapy. 26(10). 2443–2455. 48 indexed citations
13.
Wang, Shaoshuai, Haiying Sun, Jia Yao, et al.. (2015). Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis. BMC Medical Genetics. 16(1). 25–25. 13 indexed citations
14.
Li, Fei, Teng Cheng, Rui Wei, et al.. (2015). SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL. Amino Acids. 48(1). 91–101. 8 indexed citations
15.
Ma, Xiangyi, Ling Xi, Danfeng Luo, et al.. (2012). Anti-Tumor Effects of the Peptide TMTP1-GG-D(KLAKLAK)2 on Highly Metastatic Cancers. PLoS ONE. 7(9). e42685–e42685. 30 indexed citations
16.
Wang, Changyu, et al.. (2011). Primary yolk sac tumor of the endometrium. International Journal of Gynecology & Obstetrics. 114(3). 291–293. 18 indexed citations
17.
Shi, Xiaoyan, Ling Xi, Danhui Weng, et al.. (2008). Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.. Europe PMC (PubMed Central). 5 indexed citations
18.
Ma, Ding, Shixuan Wang, Jianfeng Zhou, et al.. (2008). Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer. International Journal of Biomedical Science. 4(1). 58–63. 6 indexed citations
19.
Wu, Peng, Meng Li, Hui Wang, et al.. (2005). Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Biochemical and Biophysical Research Communications. 335(1). 36–44. 26 indexed citations
20.
Xi, Ling, Tao Zhu, Peng Wu, et al.. (2005). [Expression of human telomerase reverse transcriptase in cervix cancer and its significance].. PubMed. 40(6). 407–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026